Our management team is one of the most experienced in genome editing and the cell and gene therapy industry.

Edward Lanphier

President and CEO

Geoffrey Nichol, M.B., Ch.B.

Executive Vice President, Research and Development

Ward Wolff

Executive Vice President and CFO

Dale Ando, M.D.

Vice President, Therapeutic Development and CMO

Shirley Clift

Vice President, Regulatory Affairs

Stewart Craig, Ph.D.

Vice President, Technical Operations

Curt Herberts

Vice President, Corporate Development

Michael Holmes, Ph.D.

Vice President, Research

Edward Rebar, Ph.D.

Vice President, Technology

Elizabeth Wolffe, Ph.D.

Vice President, Corporate Communications